Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-1,542
Closed -$66.2K 825
2022
Q1
$66.2K Sell
1,542
-907
-37% -$45.9K 0.02% 535
2021
Q4
$196K Buy
2,449
+280
+13% +$18.3K 0.05% 340
2021
Q3
$107K Buy
2,169
+145
+7% +$6.69K 0.03% 514
2021
Q2
$86.8K Sell
2,024
-578
-22% -$25.4K 0.02% 561
2021
Q1
$90.2K Buy
2,602
+497
+24% +$18.4K 0.03% 435
2020
Q4
$62.6K Buy
2,105
+837
+66% +$20.7K 0.02% 443
2020
Q3
$22.5K Buy
+1,268
New +$23.9K 0.01% 432

Other funds holding CALX

Exane Derivatives's CALX Position: Q2 2022 in Review

Exane Derivatives sold out of Calix (CALX) in Q2 2022, closing a stake of 1,542 shares — an estimated $66.2K sold.

Exane Derivatives first reported a position in CALX in Q3 2020 and held it in 7 quarters. The position peaked at $196K in Q4 2021. 203 funds tracked by Wall St. Rank hold CALX as of Q2 2022.

  • Exane Derivatives reported no remaining Calix position as of Q2 2022 after selling out during the quarter.
  • Exane Derivatives sold 1,542 Calix shares in Q2 2022, an estimated $66.2K.
  • Exane Derivatives first reported a position in Calix in Q3 2020 and held it in 7 quarters.
  • Exane Derivatives's Calix position peaked at $196K in Q4 2021.
  • 203 funds tracked by Wall St. Rank held Calix as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.